Changchun GeneScience Pharmaceutical Co., Ltd.: all 111 studies
Page 1 of 2. Open to participants first (48), then studies with results posted, then the rest; newest registration first within each.
- A Phase III Clinical Study of Jinpei Growth Hormone Injection in the Treatment of Short Stature Children With Small for Gestational Age (SGA)Not yet recruitingNCT07841678Phase 3
- A Phase I Study of GenSci148 Intravitreal Injection for Neovascular Age-related Macular Degeneration, Diabetic Macular Edema and Retinal Vein OcclusionNot yet recruitingNCT07817615Phase 1
- Phase 1 Clinical Study of GenSci164 InjectionNot yet recruitingNCT07790783Phase 1
- Phase IV Study of rhGH Injection in Adult Short Bowel SyndromeRecruitingNCT07691125Phase 4
- GenSci144 Tablets Phase I Clinical TrialRecruitingNCT07685210Phase 1
- A Randomized, Multicenter, Open-label, Active-controlled Phase Ib Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of Multiple Intravaginal Doses of GenSci142 in Patients With Bacterial Vaginosis (BV)RecruitingNCT07663838Phase 1
- Phase 1 Clinical Study of GenSci155 Injection in Healthy AdultsNot yet recruitingNCT07638800Phase 1
- Safety and Efficacy of Corifollitropin Alfa N02 Injection in Elderly Women Undergoing Assisted Reproductive Technology (ART)Not yet recruitingNCT07553728
- A Study of Efficacy and Safety of GenSci048 in Subjects With Active Uveitis.RecruitingNCT07547995Phase 2
- GS1-144 in Participants With Hepatic Impairment and Healthy FemaleNot yet recruitingNCT07491289Phase 1
- A Study to Evaluate the Safety, Tolerability, Pharmacokinetics of GenSci161 in Healthy Adult ParticipantsRecruitingNCT07476586Phase 1
- A Study（Phase I）of GS3-007a Dry Suspension in Healthy Chinese AdultsRecruitingNCT07473570Phase 1
- A Study (Phase 1b/2) of GenSci134 in Children With Idiopathic Short Stature (ISS)Not yet recruitingNCT07450053Phase 1/2
- A Study of GenSci134 in Children With Growth Hormone Deficiency (PGHD)Not yet recruitingNCT07450001Phase 1/2
- Phase IIb Clinical Study to Assess the Efficacy and Safety of GenSci120 Injection in Patients With Moderately to Severely Active RA Who Have an Inadequate Response to at Least One DMARDRecruitingNCT07423533Phase 2
- GenSci145 as Monotherapy or in Combination Therapy, in Participants With PIK3CA-mutated, Locally Advanced or Metastatic Solid Tumors.RecruitingNCT07407504Phase 1
- A Study of Safety, Tolerability, PK, and PD of Subcutaneous GenSci136 in Healthy Adults.RecruitingNCT07366866Phase 1
- Nanocrystalline Megestrol Acetate for Cachectic Stage Locally Advanced Hepatocellular CarcinomaNot yet recruitingNCT07356037Phase 3
- A First-in-Human Safety and Pharmacokinetic Trial of GenSci142 Administered as Single Ascending Doses in Healthy Chinese WomenNot yet recruitingNCT07302035Phase 1
- A Study of GensSci098 in Subjects With Graves' DiseaseRecruitingNCT07286656Phase 1
- A Study (Phase 1b/2) of GS3-007a Oral Treatment in Children With Growth Hormone Deficiency (PGHD)RecruitingNCT07264595Phase 1/2
- A Phase II Study of PEG-rhGH Injection for Short Children Born Small for Gestational Age: Efficacy, Safety, and PharmacokineticsRecruitingNCT07260500Phase 2
- GenSci143 in Participants With Advanced Solid TumorsRecruitingNCT07252414Phase 1
- A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of GenSci140 in Participants With Advanced Solid TumorsRecruitingNCT07251166Phase 1
- A Prospective Real-World Observational Study of Nanocrystalline Megestrol Acetate in Patients With Cancer CachexiaRecruitingNCT07243379Phase 4
- GenSci139 in Patients With Advanced Solid TumorsRecruitingNCT07230977Phase 1
- Nanocrystalline Megestrol Acetate in Concurrent Chemoradiotherapy for Locally Advanced Non-Small Cell Lung CancerRecruitingNCT07150663Phase 3
- Evaluation of the Efficacy and Safety of Megestrol Acetate in Preventing Nausea and Vomiting Induced by Highly Emetogenic ChemotherapyNot yet recruitingNCT07130617Phase 1
- A Phase III Clinical Study of Cabergoline Tablets Compared With Bromocriptine Mesylate TabletsRecruitingNCT07124221Phase 3
- Assessment of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Subcutaneous Injections of GenSci120 in Healthy Adult Participants in China.RecruitingNCT07040930Phase 1
- A Clinical Study of GenSci134 in Healthy Adults and Adult Growth Hormone Deficiency(AGHD)RecruitingNCT07016802Phase 1
- A Phase IIa Clinical Study to Assess the Efficacy and Safety of GenSci048 in Patients With Moderate to Severe Endometriosis-Associated PainRecruitingNCT06963177Phase 2
- Nano-crystalline Megestrol Acetate Combined With Standard Treatment Versus Standard Treatment for First-line Extensive-stage Small Cell Lung Cancer in the Cachexia PhaseNot yet recruitingNCT06961201Phase 3
- Clinical Study on Nanocrystalline Megestrol Acetate for Appetite Improvement and Weight Gain in Pre-Cachexia and Cachexia Stages Key Terminology AnalysisNot yet recruitingNCT06961188Phase 3
- Real-World Study on Nano-Crystalline Megestrol Acetate for Cachexia in TKI-Treated Advanced Digestive TumorsRecruitingNCT06940102
- A Phase I First-in-Human Study of GenSci128 in Patients With Solid Tumors Harboring a TP53 Y220C MutationRecruitingNCT06908434Phase 1
- A Bioequivalence Study of Two Different Processes of PEG-rhGH PreparationsNot yet recruitingNCT06840691Phase 1
- Nanocrystalline Megestrol for First-line Treatment of Advanced Gastric or Colorectal Cancer With Cancer-related FatigueRecruitingNCT06830018Not applicable
- Nano-crystalline Megestrol Acetate for Adjuvant Treatment in High-risk Head and Neck Squamous Cell Carcinoma After Surgery.Not yet recruitingNCT06772428Phase 3
- A Study to Investigate Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy With GenSci122 in Participants With Advanced Solid TumorsRecruitingNCT06772415Phase 1
- A Study of GenSci098 in Subjects With Active Thyroid Eye DiseaseRecruitingNCT06569758Phase 1
- To Evaluate Recombinant Human Follicle Stimulating Hormone-CTP Fusion Protein Injection or Placebo Combined With Chorionic Gonadotropin for InjectionNot yet recruitingNCT06561594Phase 3
- A Randomized, Double-blind, Placebo-controlled Phase II Clinical Study to Evaluate the Safety, Tolerability, Efficacy, and Pharmacokinetic Profile of Genakumab Injection in Patients With Connective Tissue Disease-associated Interstitial Lung DiseaseRecruitingNCT06189495Phase 2
- A Study for the Treatment of Dry Eye in Postmenopausal WomenRecruitingNCT06133166Phase 2
- A Study to Investigate the Safety and Efficacy of Once-weekly PEG-somatropin (GenSci004) in Children With Growth Hormone DeficiencyNot yet recruitingNCT06024967Phase 3
- A Study to Investigate Efficacy and Safety of Weekly PEG-somatropin (GenSci004) in Treatment Naive Children With Growth Hormone DeficiencyNot yet recruitingNCT06007417Phase 3
- To Evaluate the Efficacy and Safety of Genalumab for Injection in the Treatment of Active Systemic Juvenile Idiopathic Arthritis.RecruitingNCT05925452Not applicable
- To Evaluate a Phase Ia/Ib Clinical Study of EG017 in Patients With Advanced Breast Cancer.RecruitingNCT05673694Phase 1
- A Clinical Study to Evaluate the Absorption, Metabolism, and Excretion of Oral [14C]GS1-144 in Healthy Postmenopausal Female ParticipantsActive, not recruitingNCT07537231Phase 1
- To Evaluate the Impact of Smoking on PK After Single-dose Oral Administration of GS1-144 Tablets .CompletedNCT07534176Phase 1
- A Study of GS3-007a for Oral Suspension in the Diagnosis of Adult Growth Hormone Deficiency (AGHD)TerminatedNCT07259564Phase 2
- A Study on Bioequivalence of Cabergoline Tablets in Human BodyActive, not recruitingNCT07008417Phase 1
- Real-World Clinical Study for Malignant Tumor-Induced CachexiaWithdrawnNCT07008248
- The Study Will Evaluate if Leuprolide Mesylate is Safe and Effective in the Treatment of Subjects With Advanced Prostate Carcinoma, When Administered as Two Injections Six Months Apart.CompletedNCT06984159Phase 3
- A Bioavailability Study of GS1-144 Tablets in Healthy Postmenopausal WomenCompletedNCT06983925Phase 1
- A Study of Safety, Tolerability, PK, and PD of Subcutaneous GenSci120 in Healthy Adults.CompletedNCT06827457Phase 1
- A Bioequivalence Study of Two Different PEG-rhGH PreparationsCompletedNCT06797505Phase 1
- Clinical Study to Evaluate the Efficacy and Safety of GS1-144 Tablets in the Treatment of Moderate to Severe Vasomotor Symptoms in Chinese Postmenopausal Women.CompletedNCT06726850Phase 2
- A Real-world Study of Long-acting Growth Hormone Injection for Turner SyndromeCompletedNCT06722079
- A Bioequivalence Study of Two Different Dosage Form of GenakumabCompletedNCT06451848Phase 1
- Safety, Efficacy and Pharmacokinetic Behavior of Leuprolide Injectable Emulsion for Premenopausal Breast Cancer Subjects.Active, not recruitingNCT06449027Phase 3
- A Phase I Clinical Study Evaluating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Oral Dose Escalation of GS1-144 Tablets and the Effects of Food on the Pharmacokinetics of GS1-144 in a Chinese PopulationCompletedNCT06385158Phase 1
- A Bioavailability Study of Two Different PEG-rhGH Preparations.CompletedNCT06385145Phase 1
- A Bioequivalence Study of Two Different PEG-rhGH Preparations.CompletedNCT06331026Phase 1
- Long-term Follow-up Safety of a Single Injection of GenSci094 for Ovarian Stimulation Using Daily Recombinant FSH as ReferenceActive, not recruitingNCT06321107
- A Study to Assess Safety and Tolerability of GS1-144 in Healthy VolunteersCompletedNCT06204250Phase 1
- A Clinical Trail to Compare Pharmacokinetics of Two PEG-rhGH Injections With Different PreparationsCompletedNCT06135168Phase 1
- A Clinical Trial to Compare Pharmacokinetics of Two Different PEG-rhGH PreparationsCompletedNCT06135155Phase 1
- The Pharmacokinetic and Bioavailability of GenSci094 Before and After a Change in Manufacturing SiteCompletedNCT06095206Phase 1
- To Investigate Efficacy and Safety of a Single Injection of GenSci094 for Ovarian Stimulation Using Daily Recombinant FSH as ReferenceCompletedNCT06091436Phase 3
- Safety & Efffficacy of Genakumab in Patients With Frequent FlaresCompletedNCT05983445Phase 3
- A Study of the Efficacy of Genakumab in Prevention of Acute Flares in Gout Patients Initiating Urate-lowering TherapyUrate-lowering (GenSci048-202)CompletedNCT05936281Phase 2
- Safety and Efficacy of Genakumab for Injection in Patients With Gout FlareCompletedNCT05936268Phase 2
- To Evaluate the Safety and Tolerability of Multiple Doses of GS3-007a Oral Solution in Healthy Subjects.CompletedNCT05921890Phase 1
- Gentuximab Combined With Paclitaxel Compared With Placebo Combined With Paclitaxel for Gastric Adenocarcinoma.Status unknownNCT05919381Phase 3
- Clinical Study of Multiple Dose Genakumab for Injection in Chinese Healthy AdultsCompletedNCT05894148Phase 1
- A Phase 2, Randomized, Placebo-controlled, Double-blind Study of EG017 in Female Patients With Stress Urinary IncontinenceCompletedNCT05674045Phase 2
- GS3-007a Oral Solution in Healthy SubjectsCompletedNCT05611281Phase 1
- Genakumab Alone and in Combination With Tislelizumab in Patients With Advanced Malignant Solid TumorsStatus unknownNCT05441046Phase 1
- A Study to Evaluate the Efficacy and Safety of Recombinant Human Growth Hormone in Children With AchondroplasiaCompletedNCT05353192Phase 4
- Clinical Study of Genakumab for Injection in Patients With Acute GoutCompletedNCT05328531Phase 1/2
- Gentulizumab in Relapsed/Refractory Acute Myelogenous Leukemia or Myelodysplastic SyndromeTerminatedNCT05263271Phase 1
- A Study of Gentuximab in Combination With Almonertinib in EGFR Mutation-positive Metastatic NSCLCStatus unknownNCT05223595Phase 1
- Gentulizumab in Patients With Advanced Solid Malignancies and Non-Hodgkin LymphomaTerminatedNCT05221385Phase 1
- Clinical Study of Genakumab for Injection in Chinese Healthy VolunteersStatus unknownNCT04337437Phase 1
- A Study of Gentuximab + Paclitaxel in Patients With Advanced Gastric or Gastroesophageal Junction CancerCompletedNCT04053205Phase 1/2
- Efficacy and Safety of rhGH (Jintropin®) in Pediatric Participants With ISSStatus unknownNCT03635580Phase 3
- A Study to Evaluate the Efficacy and Safety of Recombinant Human Growth Hormone Injection in Patients With Prader-Willi SyndromeStatus unknownNCT03554031Phase 3
- A Study to Evaluate the Efficacy and Safety of Recombinant Human Growth Hormone in Short Stature Children Due to Chronic Kidney Disease Before TransplantationStatus unknownNCT03535415Phase 3
- Pharmacokinetics and Tolerancebility Studies of Gentuximab Injection in the Treatment ofPatients With Late Recurrence of Metastatic Solid Tumors in ChinaStatus unknownNCT03313219Phase 1
- Extension Study of Pegylated Somatropin to Treat Growth Retardation Caused by Endogenous Growth Hormone Deficiency in ChildrenStatus unknownNCT03290235Phase 4
- A Study Extension Period of PEG-somatropin (Pegylated-somatropin) in the Treatment of Children With Idiopathic Short StatureActive, not recruitingNCT03255694Phase 2
- Pegylated Somatropin (PEG Somatropin) in the Treatment of Children With Growth Hormone DeficiencyStatus unknownNCT03249480Phase 4
- A Study of Recombinant Human Growth Hormone Injection for Short Children With Small for Small for Gestational Age(SGA)Status unknownNCT03245333Phase 3
- A Study of Recombinant Human Growth Hormone Injection（JINTOPIN AQ）for Short Children With Small for SGACompletedNCT03221933Phase 2
- A Study of PEG-somatropin in the Treatment of Children With Idiopathic Short StatureStatus unknownNCT03221088Phase 2
- A Study of PEG-somatropin Injection to Treat Children of Turner SyndromeStatus unknownNCT03189160Phase 2
- A Non-inferiority Phase 2 Study to Evaluate the Safety and Efficacy of PEG-rhGH in the Treatment of AGHDStatus unknownNCT03104010Phase 2
- Clinical Study of Recombinant Human Follitropin for Injection Assisted in COH Assisted IVF-ETStatus unknownNCT03071172Phase 3
- Pegylated Somatropin (PEG Somatropin) in the Treatment of Children With Growth Hormone DeficiencyStatus unknownNCT02976675Phase 4
← Changchun GeneScience Pharmaceutical Co., Ltd. overview and focus areas